Ribonuclease T2 from Aspergillus fumigatus promotes T helper type 2 responses through M2 polarization of macrophages.
Journal
International journal of molecular medicine
ISSN: 1791-244X
Titre abrégé: Int J Mol Med
Pays: Greece
ID NLM: 9810955
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
23
01
2020
accepted:
09
04
2020
pubmed:
30
5
2020
medline:
9
3
2021
entrez:
30
5
2020
Statut:
ppublish
Résumé
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic immunological response to Aspergillus fumigatus (Af) exposure, which induces a strong T helper 2 (Th2) response via mechanisms that have yet to be elucidated. The aim of the present study was to investigate the hypothesis that T2 ribonuclease from Af (Af RNASET2) induces M2‑type macrophage polarization to produce a T helper 2 (Th2) immune response. Recombinant Af RNASET2 (rAf RNASET2) was expressed and purified in a prokaryotic pET system and BALB/c mice were immunized with rAf RNASET2 for in vivo analyses. Expression levels of M2 polarization factors were evaluated in RAW264.7 macrophages treated with rAf RNASET2 in vitro using flow cytometry, reverse transcription‑quantitative PCR, and western blot analysis. The results predicted that the mature Af RNASET2 protein (382 amino acids; GenBank no. MN593022) contained two conserved amino acid sequence (CAS) domains, termed CAS‑1 and CAS‑2, which are also characteristic of the RNASET2 family proteins. The protein expression levels of the Th2‑related cytokines interleukin (IL)‑4, IL‑10, and IL‑13 were upregulated in mice immunized with rAf RNASET2. RAW264.7 macrophages treated with rAf RNASET2 showed increased mRNA expression levels of M2 factors [arginase 1, Il‑10, and Il‑13]; however, there was no difference in cells treated with rAf RNASET2 that had been inactivated with a ribonuclease inhibitor (RNasin). The protein expression levels of IL‑10 in macrophage culture supernatant were also increased following stimulation with rAf RNASET2. In addition, rAf RNASET2 upregulated the expression of phosphorylated mitogen activated protein kinases (MAPKs) in RAW264.7 cells, whereas MAPK inhibitors attenuated rAf RNASET2‑induced IL‑10 expression in RAW264.7 cells. In conclusion, the present study reveals that high rAf RNASET2 activity is required for rAf RNASET2‑induced M2 polarization of macrophages and suggests an important immune regulatory role for Af RNASET2 in ABPA pathogenesis.
Identifiants
pubmed: 32468025
doi: 10.3892/ijmm.2020.4613
pmc: PMC7307867
doi:
Substances chimiques
Interleukin-13
0
Interleukin-10
130068-27-8
Interleukin-4
207137-56-2
Endoribonucleases
EC 3.1.-
ribonuclease T(2)
EC 3.1.27.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
718-728Références
Am J Respir Crit Care Med. 2012 Nov 15;186(10):999-1007
pubmed: 22904183
Curr Opin Pulm Med. 2003 Nov;9(6):486-91
pubmed: 14534400
Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1513-8
pubmed: 7952609
Ann Allergy Asthma Immunol. 2018 Aug;121(2):200-210.e2
pubmed: 29660515
Allergy. 2004 Feb;59(2):198-203
pubmed: 14763934
Clin Vaccine Immunol. 2010 Sep;17(9):1330-6
pubmed: 20631331
Am J Respir Cell Mol Biol. 2016 Jan;54(1):60-70
pubmed: 26072921
Parasit Vectors. 2017 Feb 17;10(1):89
pubmed: 28212670
Asthma Res Pract. 2015;1:
pubmed: 27011794
Clin Exp Ophthalmol. 2016 Aug;44(6):492-501
pubmed: 26759304
Allergy. 2015 Oct;70(10):1336-9
pubmed: 26179335
Int Arch Allergy Immunol. 2002 Oct;129(2):129-37
pubmed: 12403930
Int J Environ Res Public Health. 2019 Mar 26;16(6):
pubmed: 30917597
J Exp Med. 2009 Aug 3;206(8):1681-90
pubmed: 19635859
J Clin Invest. 2003 Oct;112(7):1058-66
pubmed: 14523043
Int J Tuberc Lung Dis. 2009 Aug;13(8):936-44
pubmed: 19723372
Am J Respir Crit Care Med. 2009 Jan 1;179(1):11-8
pubmed: 18948425
Respirology. 2009 Nov;14(8):1121-7
pubmed: 19909460
Mol Med Rep. 2019 May;19(5):3497-3504
pubmed: 30896856
Immunohorizons. 2019 Aug 6;3(8):368-377
pubmed: 31603851
Am J Respir Cell Mol Biol. 2015 Jul;53(1):87-95
pubmed: 25474274
J Asthma. 2012 May;49(4):423-33
pubmed: 22380765
J Exp Med. 2012 Sep 24;209(10):1753-67, S1
pubmed: 22966004
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Sci Rep. 2017 Feb 13;7:42413
pubmed: 28205524
Front Immunol. 2014 Nov 28;5:614
pubmed: 25506346
Parasitol Res. 2015 Jun;114(6):2371-9
pubmed: 25828812
J Clin Invest. 2019 Apr 1;129(4):1504-1515
pubmed: 30741719
Clin Exp Allergy. 2015 May;45(5):982-993
pubmed: 25270353
J Microsc Ultrastruct. 2019 Apr-Jun;7(2):53-56
pubmed: 31293885